Elevated CD86, CD11c and HLA-DQ cell surface markers confirmed the efficient transformation of monocytes into mature dendritic cells and empowered the effectiveness of the in vitro platform as a CeD model system. This evidence concerns the gene CD86 and cranioectodermal dysplasia.